Ep. 358 - Europe's biotech challenge

The BioCentury This Week podcast explores how European biotech can compete in an era prioritizing speed in clinical data generation, particularly given the rise of China's biotech industry. The discussion highlights the need for Europe to streamline clinical trials and regulatory processes to remain competitive, addressing the current fragmented regulatory framework that puts them at a disadvantage. Panelists also address the critical issue of mobilizing institutional capital, noting the underrepresentation of venture investments in European pension funds compared to their U.S. counterparts. Drug pricing in Europe is identified as a significant overhang, potentially hindering investment and market access for pharmaceutical companies. Petra Kinslova introduces the growing biotech ecosystem in the Czech Republic, spotlighting academic centers driving innovation in Prague and Brno.